What is NovoCure's current ratio?

NovoCure (NVCR) reported current ratio of 2.9× in Q1 2026.

How has NovoCure's current ratio changed year-over-year?

NovoCure's current ratio increased by 98.1% year-over-year, from 1.5× to 2.9×.

What is the long-term trend for NovoCure's current ratio?

Over 5 years (2020 to 2025), NovoCure's current ratio has grown at a -19.9% compound annual growth rate (CAGR), from 8.8× to 2.9×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

NovoCure NVCR Current ratio

Current ratio at other companies

Boston ScientificBSX

1.9×+0.4×

MedtronicMDT

2.1×+0.3×

Iovance Biotherapeutics, Inc.IOVA

3.6×-0.6×

Nuvation BioNUVB

7.4×-1.6×

Vir Biotechnology, Inc.VIR

7.1×+0.3×

ArriVent BioPharma, Inc.AVBP

14×-0.4×

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.64B-36.7%

Enterprise value$1.59B-36.3%

P/S2.4×-1.7×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Where this comes from

Calculated from NovoCure’s reported figures.

total current assets/total current liabilities=2.9×

Based on the most recent quarter.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's current ratio?: NovoCure (NVCR) reported current ratio of 2.9× in Q1 2026.
How has NovoCure's current ratio changed year-over-year?: NovoCure's current ratio increased by 98.1% year-over-year, from 1.5× to 2.9×.
What is the long-term trend for NovoCure's current ratio?: Over 5 years (2020 to 2025), NovoCure's current ratio has grown at a -19.9% compound annual growth rate (CAGR), from 8.8× to 2.9×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.